Total synthesis of the immunosuppressants myriocin and 2-epi-myriocin

Organic Letters

Volumn 10, Issue 18, 2008, Pages 4125-4128

  Jones, Matthew C ^a   Marsden, Stephen P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 EPI MYRIOCIN; 2-EPI-MYRIOCIN; IMMUNOSUPPRESSIVE AGENT; MONOUNSATURATED FATTY ACID;

ARTICLE; CHEMISTRY; ENZYME SPECIFICITY; ISOMERISM; SYNTHESIS;

FATTY ACIDS, MONOUNSATURATED; IMMUNOSUPPRESSIVE AGENTS; ISOMERISM; SUBSTRATE SPECIFICITY;

EID: 55949114981     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol801709c     Document Type: Article

References (44)

1. (a) Kluepfel, D.; Bagli, J.; Baker, H.; Charest, M.-P.; Kudelski, A.; Sehgal, S. N.; Vezina, C. J. Antibiot. 1972, 25, 109-115.
2. (b) Bagli, J.; Kluepful, D.; St-Jacques, M. J. Org. Chem. 1973, 38, 1253-1260.
3. (a) Aragozzini, F.; Manachini, P. L.; Craven, R.; Rindone, R.; Scolastico, C. Tetrahedron 1972, 13, 5493-5498.
4. (b) Destro, R.; Colombo, A. J. Chem. Soc., Perkin Trans. 2 1979, 896-899.
5. Fujita, T.; Inoue, K.; Yamamoto, S.; Ikumoto, T.; Sasaki, S.; Toyama, R.; Chiba, K.; Hoshino, Y.; Okumoto, T. J. Antibiot. 1994, 47, 208-215.
6. (a) Miyake, Y.; Kozutsumi, Y.; Nakamura, S.; Fujita, T.; Kawasaki, T. Biochem. Biophys. Res. Commun. 1995, 211, 396-403.
7. (b) Chen, J. K.; Lane, W. S.; Schreiber, S. L. Chem. Biol. 1999, 6, 221-235.
8. Glaros, E. N.; Kim, W. S.; Quinn, C. M.; Jessup, W.; Rye, K.-A.; Garner, B. J. Lipid. Res. 2008, 49, 324-331.
9. For a useful review of synthetic approaches to serine palmitoyl transferase inhibitors, see: Byun, H. S.; Lu, X.; Bittman, R. Synthesis 2006, 2447-2474.
10. (a) Banfi, L.; Beretta, M. G.; Colombo, L.; Gennari, C.; Scolastico, C. J. Chem. Soc., Chem. Commun. 1982, 488-490.
11. (b) Banfi, L.; Beretta, M. G.; Colombo, L.; Gennari, C.; Scolastico, C. J. Chem. Soc., Perkin Trans. 1 1983, 1613-1619.
12. (c) For a synthesis of anhydromyriocin using an essentially nonselective Strecker reaction, see: Just, G.; Fayette, D. R. Tetrahedron Lett. 1980, 21, 3219-3222.
13. Rao, A. V. R.; Gurjar, M. K.; Devi, T. R.; Kumar, K. R. Tetrahedron Lett. 1993, 34, 1653-1656.
14. Hatakeyama, S.; Yoshida, M.; Esumi, T.; Iwabuchi, Y.; Irie, H.; Kawamoto, T.; Yamada, H.; Nishizawa, M. Tetrahedron Lett. 1997, 38, 7887-7890.
15. (a) Deloisy, S.; Thang, T. T.; Olesker, A.; Lukacs, G. Tetrahedron Lett. 1994, 35, 4783-4786.
16. (b) Deloisy, S.; Thang, T. T.; Olesker, A.; Lukacs, G. Bull. Chim. Soc. Fr. 1996, 133, 581-585.
17. (a) Yoshikawa, M.; Yokokawa, Y.; Okuno, Y.; Murakami, N. Chem. Pharm. Bull. 1994, 42, 994-996.
18. (b) Yoshikawa, M.; Yokokawa, Y.; Okuno. Y.; Murakami, N. Tetrahedron 1995, 51, 6209-6228.
19. Sano, S.; Kobayashi, Y.; Kondo, T.; Takebayashi, M.; Maruyama, S.; Fujita, T.; Nagao, Y. Tetrahedron Lett. 1995, 36, 2097-2100.
20. Lee, K.-Y.; Oh, C.-Y.; Kim, Y.-H.; Joo, J.-E.; Ham, W.-H. Tetrahedron Lett. 2002, 43, 9361-9363.
21. (a) Oishi, T.; Ando, K.; Chida, N. Chem. Commun. 2001, 1932-1933.
22. (b) Oishi, T.; Ando, K.; Inomiya, K.; Sato, H.; Iida, M.; Chida, N. Bull. Chem. Soc. Jpn. 2002, 75, 1927-1947.
23. Torrente, S.; Alonso, R. Org. Lett. 2001, 3, 1985-1987.
24. Jones, M. C; Marsden, S. P.; Muñoz-Subtil, D. M. Org. Lett. 2006, 8, 5509-5512.
25. For related approaches to quaternary vinylglycines from dehydroamino acids, see: (a) Seebach, D.; Buerger, H. M.; Schickli, C. P. Liebigs. Ann. Chem. 1991, 669-684.
26. (b) Berkowitz, D. B.; McFadden, J. M.; Sloss, M. K. J. Org. Chem. 2000, 65, 2907-2918.
27. 2 was inferred to be of 95:5 dr, by reductive cyclization of the ester and comparison (90% ee) to racemic oxazolidinone. See ref 16.
28. See Supporting Information for details.
29. (a) Yoshikawa, M.; Yokokawa, Y.; Okuno, Y.; Yagi, N.; Murakami, N. Chem. Pharm. Bull. 1994, 42, 2662-2664.
30. (b) Yoshikawa, M.; Yokokawa, Y.; Okuno, Y.; Yagi, N.; Murakami, N. Chem. Pharm. Bull. 1995, 43, 1647-1653.
31. Blakemore, P. R.; Cole, W. J.; Kocienski, P. J.; Morley. A. Synlert 1998, 26-28.
32. For reviews of the Julia-Kocienski olefination, see: (a) Blakemore, P. R. J. Chem. Soc., Perkin Trans. 1 2002, 2563-2585.
33. (b) Plesniak, K.; Zarecki, A.; Wicha, J. Top. Curr. Chem. 2007, 27, 163-250.
34. Hayes, C. J.; Bradley, D. M.; Thomson, N. M. J. Org. Chem. 2006, 71, 2661-2665.
35. (a) Shinada, T.; Ikebe, E.; Oe, K.; Namba, K.; Kawasaki, M.; Ohfune, Y. Org. Lett. 2007, 9, 1765-1767.
36. (b) Kawasaki, M.; Shinada, T.; Hamada, M.; Ohfune, Y. Org. Lett. 2005, 7, 4165-4167.
37. (c) (66:34 dr): Trost, B. M.; Jiang, C.; Hammer, K. Synthesis 2005, 3335-3345.
38. (d) Avenoza, A.; Busto, J. H.; Corzana, F.; Peregrina, J. M.; Sucunza, D.; Zurbano, M. M. Tetrahedron: Asymmetry 2003, 14, 1037-1043.
39. (e) Donohoe, T. J.; Winter, J. G.; Helliwell, M.; Stemp, G. Tetrahedron Lett. 2001, 42, 971-974.
40. (f) Berkowitz, D. B.; Pedersen, M. L. J. Org. Chem. 1995, 60, 5368-5369.
41. For dihydroxylation of a quaternary vinylglycine bearing a chiral secondary allylic acetate at the other olefin terminus (70:30 dr), see: Trost, B. M.; Lee, C. J. Am. Chem. Soc. 2001, 123, 12191-12201.
42. Wai, J. S. M.; Marko, I.; Svendsen, J. S.; Finn, M. G.; Jacobsen, E. N.; Sharpless, K. B. J. Am. Chem. Soc. 1989, 111, 1123-1125.
43. Sharpless, K. B.; Amberg, W.; Beller, M.; Chen, H.; Hartung, J.; Kawanami, Y.; Lubben, D.; Manoury, E.; Ogino, Y.; Shibata, T.; Ukita, T. J. Org. Chem. 1991, 56, 4585-4588.
44. 1: 16 linear steps from 4, compared with the shortest previous stereoselective route of 16 steps from (Z)-but-2-ene-1,4-diol (ref 12). 7: 11 linear steps to 7 (isolated as 11) from 4, compared with 16 steps to 7 from 2-deoxy-D-glucose (ref 20).